nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biopsy helpful in diagnosing a liver mass in pregnancy: focal nodular hyperplasia
|
Yaqub, Sheraz |
|
|
402 |
10403 |
p. e10 |
artikel |
2 |
CagriSema and the link between obesity and type 2 diabetes
|
Apovian, Caroline M |
|
|
402 |
10403 |
p. 671-673 |
artikel |
3 |
China's crackdown on health-care corruption
|
Yuan, Shawn |
|
|
402 |
10403 |
p. 681-682 |
artikel |
4 |
Chinyere Ezeaka: reforming newborn health care in Nigeria
|
Davies, Rachael |
|
|
402 |
10403 |
p. 683 |
artikel |
5 |
Concerns about new proposals for haemochromatosis screening
|
McClements, Neil |
|
|
402 |
10403 |
p. 690-691 |
artikel |
6 |
Concerns about new proposals for haemochromatosis screening
|
Fish, Louise |
|
|
402 |
10403 |
p. 691-692 |
artikel |
7 |
Concerns about new proposals for haemochromatosis screening – Authors' reply
|
Adams, Paul C |
|
|
402 |
10403 |
p. 692 |
artikel |
8 |
Department of Error
|
|
|
|
402 |
10403 |
p. 692 |
artikel |
9 |
Department of Error
|
|
|
|
402 |
10403 |
p. 692 |
artikel |
10 |
Department of Error
|
|
|
|
402 |
10403 |
p. 692 |
artikel |
11 |
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
|
Frias, Juan P |
|
|
402 |
10403 |
p. 720-730 |
artikel |
12 |
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
|
Aroda, Vanita R |
|
|
402 |
10403 |
p. 693-704 |
artikel |
13 |
Improving health system performance in Mexico
|
Unger-Saldaña, Karla |
|
|
402 |
10403 |
p. 674-676 |
artikel |
14 |
Israel's judicial overhaul: a threat to the Health in All Policies approach
|
Kamin-Friedman, Shelly |
|
|
402 |
10403 |
p. 689-690 |
artikel |
15 |
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection
|
Dai, Lianpan |
|
|
402 |
10403 |
p. 687-689 |
artikel |
16 |
Oral semaglutide: an OASIS from injectables
|
Manjoo, Priya |
|
|
402 |
10403 |
p. 670-671 |
artikel |
17 |
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Knop, Filip K |
|
|
402 |
10403 |
p. 705-719 |
artikel |
18 |
Perinatal depression: a neglected aspect of maternal health
|
The Lancet, |
|
|
402 |
10403 |
p. 667 |
artikel |
19 |
Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption
|
Knaul, Felicia Marie |
|
|
402 |
10403 |
p. 731-746 |
artikel |
20 |
Strengthening Africa's voice on boards of global health initiatives
|
e Silva, Magda Robalo Correia |
|
|
402 |
10403 |
p. 677-678 |
artikel |
21 |
Syria after the earthquake
|
Skyle, Daniel |
|
|
402 |
10403 |
p. 679-680 |
artikel |
22 |
The pursuit of optimal semaglutide dosing in type 2 diabetes continues
|
Sherrill, Christina H |
|
|
402 |
10403 |
p. 668-669 |
artikel |
23 |
What do you see when you look at me? Narratives of visible disease
|
Farooki, Roopa |
|
|
402 |
10403 |
p. 684-685 |
artikel |
24 |
William Sidney Robinson
|
Watts, Geoff |
|
|
402 |
10403 |
p. 686 |
artikel |